Letter: Create a Prescription Drug Affordability Board in Illinois
I am a disability advocate for the
Consider an individual's diagnosis with traumatic life changing conditions such as MS, cancer, Parkinson's, diabetes, etc. To treat these health conditions, medication is extremely costly to the individual, but not to the manufacturer.
Everyday people with disabilities with underlying diagnosis such as the above mentioned are faced with the daily decision to either purchase the prescription, paying their rent, and/or buying groceries. High-cost drugs account for nearly one-third of all insurance premiums. As the cost of prescription drugs continues to grow, insurance companies will keep raising premiums on our diverse communities to compensate for the cost.
A Prescription Drug Affordability Board would have the potential to curb skyrocketing costs of vital medications and provide much needed relief to patients across our state. By combining data-driven research with input from a diverse group of stakeholders, that includes people with disabilities, seniors, and individuals with low to middle income, Prescription Drug Affordability Board can identify which drugs pose them most significant challenges and set limits to out-of-pocket cost for individuals.
A Prescription Drug Affordability Board is a sensible solution to a problem, if not reign in and controlled, will have devastating effects on our diverse communities. This ensures that all Illinoisans will pay only what is fair for the prescriptions they need.



Facing the healthcare beast
Aviva and Howden partner to insure innovative solar subscription service start-up
Advisor News
- Addressing the ‘menopause tax:’ A guide for advisors with female clients
- Alternative investments in 401(k)s: What advisors must know
- The modern advisor: Merging income, insurance, and investments
- Financial shocks, caregiving gaps and inflation pressures persist
- Americans unprepared for increased longevity
More Advisor NewsAnnuity News
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
- Aspida Life and WealthVest Offer a Powerful New Guaranteed Income Product with the WealthLock® Income Builder
- Lack of digital tools drives wedge between insurers, advisors
- LIMRA: Annuity sales notch 10th consecutive $100B+ quarter
- AIG to sell remaining shares in Corebridge Financial
More Annuity NewsHealth/Employee Benefits News
- Studies from Denise Wolff et al Have Provided New Data on Atopic Dermatitis (AMCP Market Insights: Beyond skin deep on the role of managed care in moderate to severe atopic dermatitis): Skin Diseases and Conditions – Atopic Dermatitis
- New Clinical Trials and Studies Findings from RAND Corporation Described (Benefit design and consumer information: results from a randomized trial): Clinical Research – Clinical Trials and Studies
- School, BOCES healthcare costs up 22%, here’s why
- Healthcare cuts threaten Sullivan's reelection chances in Alaska
- Health insurance marketplace feels growing tremors from GOP cuts
More Health/Employee Benefits NewsLife Insurance News
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
- Dan Scholz to receive NAIFA’s Terry Headley Lifetime Defender Award
- Best’s Special Report: US Property/Casualty and Health Insurers Exceed Cost of Capital; Life Insurers Narrowly Miss
- Aspida Life and WealthVest Offer a Powerful New Guaranteed Income Product with the WealthLock® Income Builder
- Lack of digital tools drives wedge between insurers, advisors
More Life Insurance News